Sale!

AMT Gene Glycine Encephalopathy Genetic Test

Original price was: $700.Current price is: $500.

-29%

The AMT Gene Glycine Encephalopathy NGS Genetic DNA Test is a comprehensive genetic analysis that identifies mutations in the AMT gene responsible for glycine encephalopathy, a rare neurological disorder. This advanced next-generation sequencing test provides crucial diagnostic information for individuals experiencing unexplained neurological symptoms, developmental delays, or seizures. By detecting specific genetic variants, the test enables early intervention and personalized treatment strategies. The test costs $500 USD and is particularly valuable for families with a history of neurological disorders or unexplained infant mortality. Our specialized genetic counseling services help interpret results and provide guidance for family planning decisions.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

AMT Gene Glycine Encephalopathy NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurological Disorders

The AMT Gene Glycine Encephalopathy NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations associated with glycine encephalopathy. This rare but serious neurological condition affects brain development and function, making early diagnosis crucial for effective management and treatment planning.

What is Glycine Encephalopathy?

Glycine encephalopathy, also known as nonketotic hyperglycinemia, is an inherited metabolic disorder characterized by abnormally high levels of the amino acid glycine in the brain and body fluids. This condition primarily affects the central nervous system, leading to progressive neurological deterioration if left undiagnosed and untreated.

What the Test Measures and Detects

Our advanced NGS (Next-Generation Sequencing) technology specifically targets the AMT gene, which encodes the enzyme aminomethyltransferase. This enzyme plays a critical role in the glycine cleavage system, and mutations in the AMT gene disrupt normal glycine metabolism.

  • Comprehensive analysis of the entire AMT gene coding region
  • Detection of point mutations, insertions, and deletions
  • Identification of known pathogenic variants associated with glycine encephalopathy
  • Assessment of novel variants of uncertain significance

Who Should Consider This Test

This genetic test is recommended for individuals presenting with specific neurological symptoms or family history patterns:

Clinical Indications and Symptoms

  • Unexplained neonatal seizures or infantile spasms
  • Developmental delays in motor skills and cognitive function
  • Hypotonia (reduced muscle tone) in infants
  • Breathing difficulties and apnea episodes
  • Family history of glycine encephalopathy or unexplained infant mortality
  • Abnormal neurological findings without clear diagnosis
  • Siblings of affected individuals for carrier screening

Benefits of AMT Gene Testing

Early genetic diagnosis through AMT gene testing provides numerous advantages for patients and families:

  • Accurate Diagnosis: Confirms or rules out glycine encephalopathy with high precision
  • Personalized Treatment: Enables targeted therapeutic interventions and medication management
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Prognostic Information: Helps predict disease progression and potential complications
  • Early Intervention: Facilitates timely implementation of supportive care and therapies

Understanding Your Test Results

Our comprehensive genetic counseling services help you interpret your AMT gene test results:

Possible Result Interpretations

  • Positive Result: Identifies pathogenic mutations confirming glycine encephalopathy diagnosis
  • Negative Result: No disease-causing mutations detected in the AMT gene
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
  • Carrier Status: Identifies individuals carrying one copy of mutated gene without symptoms

Post-Test Guidance

All positive results include detailed genetic counseling to discuss:

  • Treatment options and management strategies
  • Dietary modifications and medication considerations
  • Family testing recommendations
  • Long-term monitoring and follow-up care

Test Information and Pricing

Test Component Details
Test Name AMT Gene Glycine Encephalopathy NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before scheduling your AMT gene test, please ensure:

  • Complete clinical history documentation of the patient
  • Genetic counseling session to create detailed family pedigree chart
  • Discussion of testing implications with healthcare provider
  • Informed consent for genetic testing procedures

Nationwide Testing Availability

We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including:

  • New York City and surrounding regions
  • Los Angeles and Southern California
  • Chicago and Midwest locations
  • Houston and Texas facilities
  • Multiple East Coast and West Coast locations

Take Action Today

Don’t wait to get the answers you need for proper neurological diagnosis and management. Our team of genetic specialists and neurologists are ready to assist you with comprehensive testing and personalized care.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your AMT Gene Glycine Encephalopathy NGS Genetic DNA Test. Our genetic counselors are available to answer your questions and guide you through the testing process.

Early genetic diagnosis can make a significant difference in managing neurological conditions and planning for the future. Take the first step toward clarity and peace of mind by booking your test today.